Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data-Reference-Cited by-同舟云学术

Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data

Published:2024-02 Issue: Volume: Page:
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Schönborn Linda^ORCID,Pavord Sue^ORCID,Chen Vivien Mun Yee,Pai Menaka^ORCID,Gwarzo Dalha Haliru,Buttery Jim^ORCID,Munoz Flor M.^ORCID,Tran Huyen^ORCID,Greinacher Andreas,Law Barbara

Funder

Coalition for Epidemic Preparedness Innovations

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference83 articles.

1. Brighton Collaboration. Interim case definition of thrombosis with thrombocytopenia syndrome (TTS). 2021. Last accessed 23 October 2023; Available from: https://brightoncollaboration.us/thrombosis-with-thrombocytopenia-syndrome-interim/.

2. The Brighton Collaboration: enhancing comparability of vaccine safety data;Kohl;Pharmacoepidemiol Drug Saf,2003

3. The Brighton Collaboration: Creating a global standard for case definitions (and guidelines) for adverse events following immunization;Kohl,2005

4. Oxford University. Oxford University welcomes UK regulatory emergency use authorisation of coronavirus vaccine. 2020. Last accessed 27 November 2023; Available from: https://www.ox.ac.uk/news/2020-12-30-oxford-university-welcomes-uk-regulatory-emergency-use-authorisation-coronavirus.

5. European Medicines Agency. EMA recommends COVID-19 Vaccine AstraZeneca for authorisation in the EU. 2021. Last accessed 27 November 2023; Available from: https://www.ema.europa.eu/en/news/ema-recommends-covid-19-vaccine-astrazeneca-authorisation-eu.